Company · CIK 0001006281
Protalix BioTherapeutics, Inc.
PLXSearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$2.56−$0.06 (−2.29%)
PLX · Last trade
- Prev close
- $2.62
- Range (28d)
- $2.56 – $2.84
On the record
Recent filings
- SCHEDULE 13GPLXProtalix BioTherapeutics, Inc.0002086358-26-000006 · 7.1 KBSEC(opens sec.gov)
- 10-QPLXQuarterly update0001104659-26-094444 · 4.6 MBSEC(opens sec.gov)
- 8-KPLXCurrent report0001104659-26-094433 · 394.4 KBSEC(opens sec.gov)
- SCHEDULE 13GPLXProtalix BioTherapeutics, Inc.0002012383-26-002863 · 11.0 KBSEC(opens sec.gov)
- 8-KPLXCurrent report0001104659-26-077790 · 380.1 KBSEC(opens sec.gov)
- 8-KPLXCurrent report0001104659-26-064850 · 4.6 MBSEC(opens sec.gov)
- 10-QPLXQuarterly update0001104659-26-059756 · 3.7 MBSEC(opens sec.gov)
- 8-KPLXCurrent report0001104659-26-059749 · 373.7 KBSEC(opens sec.gov)
- 10-KPLXAnnual report0001104659-26-029858 · 11.6 MBSEC(opens sec.gov)
- 8-KPLXCurrent report0001104659-26-029846 · 393.2 KBSEC(opens sec.gov)
Insiders
- Akirov AlfredDirector
- Almon Einat BrillSVP, Chief Development Officer
- Aviezer DavidDirector, President & CEO
- Bar-Shalev AmosDirector
- Bashan DrorDirector, PRESIDENT AND CEO
- Ben Zvi ShmuelDirector
- Boudes Pol FDirector
- Bronfeld ZeevDirector
- Camber Capital Management LP10% Owner
- Dexcel Pharma Technologies Ltd.10% Owner
Tickers
Addresses
business
2 UNIVERSITY PLAZA SUITE 100
HACKENSACK, NJ, 07601
mailing
2 UNIVERSITY PLAZA SUITE 100
HACKENSACK, NJ, 07601
Former names
- ORTHODONTIX INC2007-02-22
- EMBASSY ACQUISITION CORP1998-03-31
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies